CXCR4pos circulating progenitor cells coexpressing monocytic and endothelial markers correlating with fibrotic clinical features are present in the peripheral blood of patients affected by systemic sclerosis

Haematologica

Volumn 93, Issue 8, 2008, Pages 1233-1237

  Campioni, Diana ^a   Lo Monaco, Andrea ^a   Lanza, Francesco ^a   Moretti, Sabrina ^a   Ferrari, Luisa ^a   Fotinidi, Maria ^a   La Corte, Renato ^a   Cuneo, Antonio ^a   Trotta, Francesco ^a  

^a UNIVERSITY OF FERRARA   (Italy)

Author keywords

Circulating hematopoietic progenitor cells; CXCR4; Endothelial like cells; Monocytes; Systemic sclerosis

Indexed keywords

CD31 ANTIGEN; CD34 ANTIGEN; CD45 ANTIGEN; CELL MARKER; CHEMOKINE RECEPTOR CXCR4; STEM CELL FACTOR RECEPTOR; STROMAL CELL DERIVED FACTOR 1; VASCULOTROPIN;

ADULT; ARTICLE; CELL LINE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; ENDOTHELIUM CELL; ERYTHROID PRECURSOR CELL; FEMALE; FIBROSIS; FLOW CYTOMETRY; HUMAN; INFORMATION SCIENCE; MALE; MONOCYTE; PROTEIN EXPRESSION; SPINDLE CELL; SYSTEMIC SCLEROSIS;

ADULT; AGED; ANTIGENS, CD; AUTOANTIBODIES; CYTOKINES; ENDOTHELIAL CELLS; FIBROSIS; HEMATOPOIETIC STEM CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; MONOCYTES; RECEPTORS, CXCR4; REFERENCE VALUES; SCLERODERMA, SYSTEMIC;

EID: 48749113166     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: 10.3324/haematol.12526     Document Type: Article

References (24)

1. Asahara T, Masuda H, Takahashi T, Kalka C, Pastore C, Silver M, et al. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res 1999;85:221-8.
2. Rafii S, Lyden D. Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration. Nat Med 2003;9:702-12.
3. Dignat-George F, Sampol J, Lip G, Blann AD. Circulating endothelial cells: realities and promises in vascular disorders. Pathophysiol Haemost Thromb 2004;33:495-9.
4. Hill JM, Zalos G, Halcox JPJ, Schenke WH, Waclawiw MA, Quyyumi AA, et al. Circulating progenitor cells, vascular function and cardiovascular risk. N Engl Med 2003;348:593-600.
5. Beerepoot LV, Mehra N, Vermaat JSP, Zonnenberg BA, Gebbink MFGB, Voest EE. Increased levels of viable circulating endothelial cells are an indicator of progressive disease in cancer patients. Ann Oncol 2004;15:139-45.
6. Dabusti M, Lanza F, Campioni D, Castagnari B, Tieghi A, Moretti S, et al. CXCR-4 expression on bone marrow CD34+ cells prior to mobilization can predict mobilization adequacy in patients with hematologic malignancies. J Hematother Stem Cell Res 2003;12:425-34.
7. Ruiz de Almodovar C, Luttun A, Carmeliet P. An SDF-1 trap for myeloid cells stimulates angiogenesis. Cell 2006;124:18-21.
8. Medsger TA Jr, Steen VD. Classification, prognosis. In: Clements PJ, Furst DE, editors. Systemic sclerosis. 2nd ed. Philadelphia: Lippincott Williams & Wilkins;1996. p. 51-79.
9. Allanore Y, Batteux F, Avouac J, Assous N, Weill B, Kahan A. Levels of circulating progenitor cells in systemic sclerosis. Clin Exp Rheumatol 2007;25:60-6.
10. Del Papa N, Colombo G, Fracchiolla N, Mazzeo Moronetti L, Ingegnoli F, Maglione W, et al. Circulating endothelial cells as a marker of ongoing vascular disease in Systemic Sclerosis. Arth Rheum 2004;50:1296-304.
11. Kuwana M, Okazaki Y, Yashuoka H, Kawakami Y, Ikeda Y. Defective vasculogenesis in Systemic Sclerosis. Lancet 2004;364:603-10.
12. Grisar J, Aletaha D, Steiner CW, Kapral T, Steiner S, Seidinger D, et al. Depletion of endothelial progenitor cells in the peripheral blood of patients with Rheumatoid Arthritis. Circulation 2005;11:204-11.
13. Schmeisser A, Strasser RH. Phenotypic overlap between hematopoietic cells with suggested angioblastic potential and vascular endothelial cells. J Hematother Stem Cell Res 2002;11:69-79.
14. Zhao Y, Glesne D, Huberman E. A human peripheral blood monocyte-derived subset acts as pluripotent stem cells. PNAS 2003;100:2426-31.
15. Le Roy EC, Black C, Fleischmajer R, Jablonska S, Kreig T, Medsgeeer TA. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 1988;15:202-5.
16. Warrick JH, Bhalla M, Schabel SI, Silver RM. High resolution computed tomography in early scleroderma lung disease. J Rheumatol 1991;18:1520-8.
17. Campioni D, Moretti S, Ferrari L, Punturieri M, Castoldi GL, Lanza F. Immunophenotypic heterogeneity of bone marrow derived mesenchymal stromal cells from patients with hematologic disorders: correlation with the bone marrow microenvironment. Haematologica 2006;91:364-8.
18. Campioni D, Lanza F, Moretti S, Ferrari L, Cuneo A. Loss of Thy-1 (CD90) antigen expression on mesenchymal stromal cells from haematologic malignancies is induced by in vitro angiogenic stimuli and is associated with peculiar functional and phenotypic characteristics. Cytotherapy 2007;21:378-81.
19. Dominici M, Campioni D, Lanza F, Luppi M, Barozzi P, Pauli S, et al. Angiogenesis in multiple myeloma: correlation between in vitro endothelial colonies growth (CFUEn) and clinical-biological features. Leukemia 2001;15:171-6.
20. Yoder MC, Mead LE, Prater D, Krier TR, Mroueh KN, Fang Li, et al. Redefining endothelial progenitor cell via clonal analysis and hematopoietic stem/progenitor cell principals. Blood 2007;109:1801-9.
21. Lanza F, Latorraca A, Moretti S, Tomasi P. Colorazioni e tecniche di indagine morfologica e immunologia. In: Piccin, Padova Editor. Trattato Italiano di Medicina di Laboratorio; Vol. V 1999.
22. Strijbos MH, Kraan J, den Bakker MA, Lambrecht BN, Sleijfer S, Gratama JW. Cells meeting our immunophenotypic criteria of endothelial cells are large platelets. Cytometry B Clin 2006;70B:56-62.
23. Bauman CI, Bailey AS, Li W, Ferkowicz MJ, Yoder MC, Fleming WH. PECAM-1 is expressed on hematopoietic stem cells throughout ontogeny and identify a population of erythroid progenitors. Blood 2004;104:1010-16.
24. Phillips RJ, Burdick MD, Hong K, Lutz MA, Murray LA, Jing Xue, et al. Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis. J Clin Invest 2004;114:438-46.